|
| 37026186 | Electronic Dashboard to Improve Outcomes in Pediatric Patients With Type 1 Diabetes Mellitus. | | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 35604410 | Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. | Neuro Oncol | 2023 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 35703183 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2022 |
| 36072789 | Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data. | Front Oncol | 2022 |
| 35552452 | Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry. | Neuro Oncol | 2022 |
| 35611273 | Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. | Neurooncol Adv | 2022 |
| 35218656 | Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials. | Neuro Oncol | 2022 |
| 34643931 | Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future. | Molecular Biology Reports | 2021 |
| 33631016 | A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2021 |
| 33471107 | Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma. | Neuro Oncol | 2021 |
| 33507822 | NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. | J Clin Oncol | 2021 |
| 34303558 | Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae. | Current Problems in Cancer | 2021 |
| 32876801 | Benign skull and subdural lesions in patients with prior medulloblastoma therapy. | Childs Nerv Syst | 2021 |
| 33336845 | Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children. | Pediatr Blood Cancer | 2021 |
| 33405376 | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). | Pediatr Blood Cancer | 2021 |
| 32937871 | Pediatric Suprasellar Germ Cell Tumors: A Clinical and Radiographic Review of Solitary vs. Bifocal Tumors and Its Therapeutic Implications. | Cancers | 2020 |
| 32374469 | Symptom burden trajectories experienced by patients with brain tumors. | Cancer | 2020 |
| 32304218 | Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial. | Neuro Oncol | 2020 |
| 32236425 | A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study. | Neuro Oncol | 2020 |
| 32393959 | Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. | Neuro Oncol | 2020 |
| 33318517 | Combined PI3Kα-mTOR Targeting of Glioma Stem Cells. | Scientific Reports | 2020 |
| 33040274 | A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas. | J Neurooncol | 2020 |
| 32817593 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2020 |
| 32674144 | Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma. | Neurosurgery | 2020 |
| 32506137 | MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. | Neuro Oncol | 2020 |
| 32502458 | Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 31151904 | Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. | Lancet Oncol | 2019 |
| 30426667 | Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors. | Pediatr Blood Cancer | 2019 |
| 31492956 | Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma. | Scientific Reports | 2019 |
| 31227500 | Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma. | Clin Cancer Res | 2019 |
| 30842251 | Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma. | Molecular Cancer Research | 2019 |
| 30670636 | Transcriptional repressor REST drives lineage stage-specific chromatin compaction at <i>Ptch1</i> and increases AKT activation in a mouse model of medulloblastoma. | Sci Signal | 2019 |
| 30997512 | Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients. | Neuro Oncol | 2019 |
| 29741745 | Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2018 |
| 28449033 | Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. | Neuro Oncol | 2018 |
| 29042487 | Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation. | Mol Cancer Res | 2018 |
| 29352211 | HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma. | Scientific Reports | 2018 |
| 29618625 | Getting serious about the early-life epilepsies: Lessons from the world of pediatric oncology. | Neurology | 2018 |
| 29170909 | New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. | J Neurooncol | 2018 |
| 29750396 | A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. | Pediatr Blood Cancer | 2018 |
| 29746225 | Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. | J Clin Oncol | 2018 |
| 27510726 | Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. | Neuro Oncol | 2017 |
| 28821206 | Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. | Neuro Oncol | 2017 |
| 28339824 | A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. | Neuro Oncol | 2017 |
| 28797854 | Computerized Adaptive Testing in Pediatric Brain Tumor Clinics. | J Pain Symptom Manage | 2017 |
| 28447250 | Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors. | Qual Life Res | 2017 |
| 29138631 | SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors. | Sarcoma | 2017 |
| 29435175 | REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. | Oncotarget | 2017 |